Asia-Pacific Americas Africa Europe Middle East

AMGEN ILAC TICARET LTD.STI.

Company Profile:

Company Introduction: AMGEN ILAC TICARET LTD.STI.

AMGEN ILAC TICARET LTD.STI. is the Turkish subsidiary of Amgen Inc., a leading global biotechnology company headquartered in the United States. This entity primarily operates as a commercial, marketing, and distribution arm within Turkey.

Regarding whether it is a factory or a trader:

It is a trader (a distributor and marketing entity).

AMGEN ILAC TICARET LTD.STI. is responsible for the import, marketing, sales, and distribution of Amgen's innovative biopharmaceutical products across Turkey. While Amgen Inc. globally conducts research, development, and manufacturing of its medicines at various production facilities, the Turkish "Ticaret Ltd. Sti." (Trade Limited Company) designation signifies its role as a local commercial and trading operation. Its core mission is to make Amgen's advanced treatments for serious illnesses, including those in oncology, nephrology, bone health, and cardiovascular diseases, accessible to patients in the Turkish market.

Enterprise Products

Here are some of the products that AMGEN ILAC TICARET LTD.STI. in Turkey manufactures or sells:

* Aranesp

* Enbrel

* Neulasta

* Prolia

* XGEVA

* KYPROLIS

* BLINCYTO

* REPATHA

Please note that product availability may vary. It is always best to consult with a healthcare professional for specific medical advice.

Business Registration Information:

Manager:

Güldem Yetkin

Phone:

+90 212 305 77 00

E-mail:

No Data

Official Website:
Address:

Levent Mah. Buyukdere Cad. No:199 Kat: 13 Levent 199 Plaza Sisli Istanbul, Turkey

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.